Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Primrose Healthcare has launched an alcohol app designed to help hepatitis C patients overcome alcohol addiction by providing personalized education and resources through goal setting, alerts, coaching and ongoing feedback.
A study published by JAMA Ophthalmology has found that the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute.
CMS has released a public use file for the 2013 Medicare Current Beneficiary Survey (MCBS), allowing researchers easy access to select data to analyze health disparities and access to care.
The Center for Medical Interoperability (CMI) held a panel discussion with CMI Executive Director Ed Cantwell, Zane Burke, president of Cerner, and Mike Schatzlein, senior vice president at Ascension Health.
Three weeks after healthcare researchers revealed that medical errors are the third leading cause of death in the U.S., the federal government’s Agency for Healthcare Research and Quality (AHRQ) has released a new online toolkit designed to help providers communicate with patients and loved ones when something goes wrong.
Counties across northern California, Central Valley and Sierra Nevada are expanding healthcare for lower-income residents, no matter their immigration status.
The National Institutes of Health has awarded a five-year, $1.6 million grant to a firm focusing on developing software to ease determining eligibility for public health programs.
Given the same clinical scenarios, surgeons came up with wildly different opinions on the potential risks and benefits, which was a major factor in their decision whether or not to operate
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
